Product Research
Paclitaxel
Docetaxel
Vinorelbine
Ifosfamide
Mesna
Pirarubicin
Aclarubicin
Adriamycin
Daunorubicin
Vincristine
Bleomycin
Lastet



 

Aclarubicin hydrochloride for injection (ACR) is a kind of antitumor antibiotic developed by Professor H. Umezawa of Micro-biochemistry Research Center of Japan. It has been applied for got compounds patent of Japan. It is applied to cure acute leukemia and malignant lymphoma, and when it was tried to cure other solid tumor, we got certain clinical curative effects.

Aclarubicin is a breed of "Catalogue of National Essential Drugs". Use imported high-quality feedstock and advanced productive technique, the aclarubicins produced by our corporation have high performance and adequate quality. They are generally accepted by most clinicians and patients.



 
  国家食品药品监督管理局世界卫生组织中国医学科学院深圳万维医药贸易有限公司  
  深圳万乐药业有限公司 版权所有
Copyright © 2004 Shenzhen Main Luck Phar maceuticals Inc. All right reserved
Email:wanle@wanle.com.cn
 
Home Site Map English Version